A method of treating and/or preventing symptoms ofDoose syndrome in a patient such as a patient previously diagnosed withDoose syndrome, by administering an effective dose of fenfluramine orits pharmaceutically acceptable salt to that patient. Doose syndromepatients are treated at a preferred dose of less than about 10.0 to about 0.01mg/kg/day.